Ofer Gofrit Selected Research

Radiotherapy

1/2007

Anti-HER2 cationic immunoemulsion as a potential targeted drug delivery system for the treatment of prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ofer Gofrit Research Topics

Disease

5	Neoplasms (Cancer) 07/2020 - 10/2004
3	Urinary Bladder Neoplasms (Bladder Cancer) 07/2020 - 10/2004
2	Prostatic Neoplasms (Prostate Cancer) 03/2009 - 01/2007
1	Neoplasm Metastasis (Metastasis) 03/2009
1	Hypersensitivity (Allergy) 01/2007
1	Transitional Cell Carcinoma 10/2004
1	Carcinoma (Carcinomatosis) 10/2004

Drug/Important Bio-Agent (IBA)

2	Paclitaxel (Taxol)FDA LinkGeneric 03/2009 - 01/2007
1	Coloring Agents (Dyes)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	PolymersIBA 03/2009
1	SuspensionsIBA 03/2009
1	Ointments (Pastes)IBA 03/2009
1	Delayed-Action PreparationsIBA 03/2009
1	cremophor ELIBA 01/2007
1	Trastuzumab (Herceptin)FDA Link 01/2007
1	Docetaxel (Taxotere)FDA Link 01/2007
1	Monoclonal AntibodiesIBA 01/2007
1	EmulsionsIBA 01/2007
1	PalmitatesIBA 01/2007
1	Taxoids (Taxanes)IBA 01/2007
1	Drinking WaterIBA 10/2004
1	ButylhydroxybutylnitrosamineIBA 10/2004
1	Insulin-Like PeptidesIBA 10/2004
1	Complementary DNA (cDNA)IBA 10/2004
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2004

Therapy/Procedure

1	Transurethral Resection of Bladder 07/2020
1	Injections 03/2009
1	Drug Therapy (Chemotherapy) 01/2007
1	Radiotherapy 01/2007
1	Therapeutics 01/2007